Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Chikungunya Market from 2024 to 2025?
In the past few years, the size of the Chikungunya market has seen significant growth. An increase from $0.59 billion in 2024 to $0.65 billion in 2025 is projected, with a compound annual growth rate (CAGR) of 9.8%. Several factors have contributed to this growth during the historic period, including increased per capita healthcare spending, a rise in the incidence of new and recurring infectious diseases, an upsurge in personal disposable income, climate change, and heightened awareness about mosquito-borne diseases.
What Is the Projected Market Size of the Chikungunya Market?
Expectations for a robust increase in the chikungunya market size are high for the coming years, with projections indicating a growth to $0.93 billion by 2029 at a CAGR of 9.4%. Growth factors for this period include the global increase in clinical trials, an aging population, the growing demand for immunization, and the rise in both government and private initiatives and investments coupled with supportive policies. Key emerging trends during this period consist of biotech innovations in vaccine production, emergence of new vaccines, application of CRISPR and AI for creative solutions, strategic partnerships across pharmaceutical companies, and the inclusion of telemedicine services.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21137&type=smp
Who are the Major Competitors in the Chikungunya Market Outlook?
Major companies operating in the chikungunya market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Quest Diagnostics Incorporated, Eurofins Scientific SE, Grifols Diagnostic Solutions Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Euroimmun AG, Evotec SE, Valneva SE, ELITechGroup S.A.S., Vaxart Inc., BioPerfectus Biotechnology Co. Ltd., CTK Biotech Inc., Creative Diagnostics Inc., Inovio Pharmaceuticals Inc., Biotrol Laboratories Pvt. Ltd.
What Is Fueling Growth in the Chikungunya Market?
The escalating occurrences of diseases transmitted by mosquitoes is anticipated to fuel the expansion of the chikungunya market in the future. Illnesses like chikungunya, dengue and zika virus, spread by infected aedes mosquitoes, present major worldwide public health issues. The upsurge in such diseases globally is a result of factors such as climate change, urban growth, deforestation, accumulation of stagnant water, insufficient measures for vector control, a rise in international travel, and resistance to insecticides. Treatments for chikungunya aid those afflicted by mosquito-borne diseases by alleviating symptoms like fever, joint pain and inflammation, while enhancing comfort and mobility, lowering the possibility of complications, and aiding recovery through hydration, pain management and supportive care. For example, in December 2024, the UK Health Security Agency, a government agency based in the UK, reported a staggering increase of 201% in dengue cases amongst travellers returning to England, Wales, and Northern Ireland during the period of January to June 2024, with 473 cases compared to 157 cases during the same period in 2023. Hence, the global rise in mosquito-borne diseases is propelling the progress of the chikungunya market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21137&type=smp
Which Chikungunya Market Segments Are Growing the Fastest?
The chikungunya market covered in this report is segmented –
1) By Type: Antiviral Drugs, Herbal And Complementary Treatments, Supportive Care, Vaccines
2) By Product Form: Liquid Form, Powder, Solid Form
3) By Disease Stage: Acute, Chronic, Post-Infection
4) By Sales Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Supermarkets
5) By End User: Caregivers, Healthcare Professionals, Patients
Subsegments:
1) By Antiviral Drugs: Nucleoside Analogues, Protease Inhibitors
2) By Herbal And Complementary Treatments: Ayurvedic Remedies, Homeopathic Treatments, Traditional Chinese Medicine
3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen), Fluid Therapy, Physiotherapy
4) By Vaccines: Live-Attenuated Vaccines, Inactivated Vaccines, mRNA-Based Vaccines
Which Industry Trends Are Shaping the Future of the Chikungunya Market?
Leading corporations in the chikungunya market are concentrating their efforts on inventing novel vaccines to increase immunity, prevent outbreaks, and tackle the rising international health issue of chikungunya virus infections. A live attenuated chikungunya vaccine employs a diminished version of the chikungunya virus to provoke immune reaction without initiating the disease itself, thus providing enduring protection. For example, Valneva SE, a biotechnology firm based in France, unveiled IXCHIQ in November 2023, a live attenuated chikungunya vaccine that has been approved by the Food and Drug Administration (FDA), an agency of the US government. This endorsement was granted under a fast-tracked approval process based on the measurement of anti-CHIKV neutralizing antibody levels, with the continued approval depending on the authentication of clinical benefits in follow-up studies. Valneva garnered a Priority Review Voucher (PRV) from the FDA, which the company plans to utilize to finance its research and development activities. Ixchiq is administered as a single-shot injection into the muscle containing a live, weakened version of the chikungunya virus, potentially causing symptoms in recipients similar to those of the chikungunya disease.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/chikungunya-global-market-report
Which Countries Are Leading the Chikungunya Market?
North America was the largest region in the chikungunya market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chikungunya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21137
This Report Delivers Insight On:
1. How big is the chikungunya market, and how is it changing globally?
2. Who are the major companies in the chikungunya market, and how are they performing?
3. What are the key opportunities and risks in the chikungunya market right now?
4. Which products or customer segments are growing the most in the chikungunya market?
5. What factors are helping or slowing down the growth of the chikungunya market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model